Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06700811 · ClinicalTrials.gov registry record · Phase 1

Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

A Phase 1 study of Developmental and Epileptic Encephalopathies and Epileptic Spasms, sponsored by Heather Olson.

Recruiting
Registry status
Phase 1
Development phase
10
Enrollment target
1
Study location

NCT06700811 is a Phase 1 study of Developmental and Epileptic Encephalopathies and Epileptic Spasms that is actively recruiting participants, run by Heather Olson. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06700811, a Phase 1 study of Developmental and Epileptic Encephalopathies and Epileptic Spasms, is actively recruiting participants, sponsored by Heather Olson.

RECRUITING
Registry status
Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Epileptic spasms (ES) are a predominantly infantile seizure type observed frequently in certain genetic disorders. Ketogenic diet (high ratio of fat to carbohydrate/protein) is an established non-medication treatment for difficult to control seizures, including ES. Because ES are associated with worse developmental and cognitive outcomes if not detected or treated quickly and effectively, this trial aims to test the ketogenic diet to prevent ES in this high-risk population. This trial is a single-center pilot study of 10 infants with genetic seizure disorders to establish if the protocol of early ketogenic diet administration and ES evaluation is safe and feasible.

Interventions

  • DRUG Ketogenic diet

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-08-11
Est. Completion 2028-05
Phase Phase 1

Sponsor

Heather Olson

1 total trials

What the Registry Record Tells You About NCT06700811

The ClinicalTrials.gov registry entry for NCT06700811 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heather Olson, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Developmental and Epileptic Encephalopathies appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic diet is the first listed.

NCT06700811 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06700811 about?

NCT06700811 is a clinical study titled "Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies". Epileptic spasms (ES) are a predominantly infantile seizure type observed frequently in certain genetic disorders. Ketogenic diet (high ratio of fat to carbohydrate/protein) is an established non-medication treatment for difficult to control seizures, including ES. Because ES are associated with wor...

What is the current status of trial NCT06700811?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-08-11. Estimated completion is 2028-05.

What conditions does trial NCT06700811 study?

This clinical trial studies the following conditions: Developmental and Epileptic Encephalopathies, Epileptic Spasms, Genetic Epilepsy, Neonatal and Infant Epilepsy.

What interventions are being tested in trial NCT06700811?

The interventions under investigation include: Ketogenic diet (DRUG).

Who is sponsoring clinical trial NCT06700811?

This trial is sponsored by Heather Olson, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06700811 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.